Skip to main content
Erschienen in: Journal of General Internal Medicine 1/2017

07.03.2017 | Original Research

A Randomized, Controlled Multisite Study of Behavioral Interventions for Veterans with Mental Illness and Antipsychotic Medication-Associated Obesity

verfasst von: Zachary D. Erickson, BA, CCRP, Crystal L. Kwan, MPH, RD, CDE, Hollie A. Gelberg, PhD, RD, Irina Y. Arnold, MS, MD, Valery Chamberlin, MD, Jennifer A. Rosen, PharmD, BCPP, Chandresh Shah, MD, Charles T. Nguyen, MD, Gerhard Hellemann, PhD, Dixie R. Aragaki, MD, Charles F. Kunkel, MD, Melissa M. Lewis, PhD, Neena Sachinvala, MD, Patrick A. Sonza, RN, Joseph M. Pierre, MD, Donna Ames, MD

Erschienen in: Journal of General Internal Medicine | Sonderheft 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Weight gain and other metabolic sequelae of antipsychotic medications can lead to medication non-adherence, reduced quality of life, increased costs, and premature mortality. Of the approaches to address this, behavioral interventions are less invasive, cost less, and can result in sustained long-term benefits.

Objective

We investigated behavioral weight management interventions for veterans with mental illness across four medical centers within the Veterans Affairs (VA) Healthcare System.

Design

We conducted a 12-month, multi-site extension of our previous randomized, controlled study, comparing treatment and control groups.

Participants

Veterans (and some non-veteran women) diagnosed with mental illness, overweight (defined as having a BMI over 25), and required ongoing antipsychotic therapy.

Interventions

One group received “Lifestyle Balance” (LB; modified from the Diabetes Prevention Program) consisting of classes and individual nutritional counseling with a dietitian. A second group received less intensive “Usual Care” (UC) consisting of weight monitoring and provision of self-help.

Main Measures

Participants completed anthropometric and nutrition assessments weekly for 8 weeks, then monthly. Psychiatric, behavioral, and physical assessments were conducted at baseline and months 2, 6, and 12. Metabolic and lipid laboratory tests were performed quarterly.

Key Results

Participants in both groups lost weight. LB participants had a greater decrease in average waist circumference [F(1,1244) = 11.9, p < 0.001] and percent body fat [F(1,1121) = 4.3, p = 0.038]. Controlling for gender yielded statistically significant changes between groups in BMI [F(1,1246) = 13.9, p < 0.001]. Waist circumference and percent body fat decreased for LB women [F(1,1243) = 22.5, p < 0.001 and F(1,1221) = 4.8, p = 0.029, respectively]. The majority of LB participants kept food and activity journals (92%), and average daily calorie intake decreased from 2055 to 1650 during the study (p < 0.001).

Conclusions

Behavioral interventions specifically designed for individuals with mental illness can be effective for weight loss and improve dietary behaviors. “Lifestyle Balance” integrates well with VA healthcare’s patient-centered “Whole Health” approach.
ClinicalTrials.gov identifier NCT01052714.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry. 2002;63(10):856–865.CrossRefPubMed Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC. The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry. 2002;63(10):856–865.CrossRefPubMed
2.
Zurück zum Zitat Wirshing DA, Pierre JM, Eyeler J, Weinbach J, Wirshing WC. Risperidone-associated new-onset diabetes. Biol Psychiatry. 2001;50(2):148–149.CrossRefPubMed Wirshing DA, Pierre JM, Eyeler J, Weinbach J, Wirshing WC. Risperidone-associated new-onset diabetes. Biol Psychiatry. 2001;50(2):148–149.CrossRefPubMed
3.
Zurück zum Zitat Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC. Novel antipsychotics and new onset diabetes. Biol Psychiatry. 1998;44(8):778–783.CrossRefPubMed Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC. Novel antipsychotics and new onset diabetes. Biol Psychiatry. 1998;44(8):778–783.CrossRefPubMed
4.
Zurück zum Zitat Wirshing DA, Wirshing WC, Kysar L, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry. 1999;60(6):358–363.CrossRefPubMed Wirshing DA, Wirshing WC, Kysar L, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry. 1999;60(6):358–363.CrossRefPubMed
5.
Zurück zum Zitat Das C, Mendez G, Jagasia S, Labbate LA. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments. Ann Clin Psychiatry. 2012;24(3):225–239.PubMed Das C, Mendez G, Jagasia S, Labbate LA. Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments. Ann Clin Psychiatry. 2012;24(3):225–239.PubMed
6.
Zurück zum Zitat Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res. 2004;66(1):51–57.CrossRefPubMed Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res. 2004;66(1):51–57.CrossRefPubMed
7.
Zurück zum Zitat Wong MMC, Chen EYH, Lui SSY, Tso S. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder. Clin Schizophr Relat Psychoses. 2011;5(3):135–141.CrossRefPubMed Wong MMC, Chen EYH, Lui SSY, Tso S. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder. Clin Schizophr Relat Psychoses. 2011;5(3):135–141.CrossRefPubMed
8.
Zurück zum Zitat US Department of Health and Human Services: Agency for Healthcare Research and Quality. National Statistics on Mental Health Hospitalizations: Schizophrenia and other psychotic disorders. Healthcare Cost and Utilization Project (H-CUPnet). http://hcupnet.ahrq.gov/HCUPnet.jsp. Accessed June 29, 2016. US Department of Health and Human Services: Agency for Healthcare Research and Quality. National Statistics on Mental Health Hospitalizations: Schizophrenia and other psychotic disorders. Healthcare Cost and Utilization Project (H-CUPnet). http://​hcupnet.​ahrq.​gov/​HCUPnet.​jsp. Accessed June 29, 2016.
9.
Zurück zum Zitat Ames D, Carr-Lopez SM, Gutierrez MA, et al. Detecting and managing adverse effects of antipsychotic medications. Psychiatr Clin North Am. 2016;39(2):275–311.CrossRefPubMed Ames D, Carr-Lopez SM, Gutierrez MA, et al. Detecting and managing adverse effects of antipsychotic medications. Psychiatr Clin North Am. 2016;39(2):275–311.CrossRefPubMed
10.
Zurück zum Zitat Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015;72(12):1172.CrossRefPubMed Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015;72(12):1172.CrossRefPubMed
11.
Zurück zum Zitat Rutledge T, Groesz LM, Savu M. Psychiatric factors and weight loss patterns following gastric bypass surgery in a veteran population. Obes Surg. 2011;21(1):29–35.CrossRefPubMed Rutledge T, Groesz LM, Savu M. Psychiatric factors and weight loss patterns following gastric bypass surgery in a veteran population. Obes Surg. 2011;21(1):29–35.CrossRefPubMed
12.
Zurück zum Zitat Semanscin-Doerr DA, Windover A, Ashton K, Heinberg LJ. Mood disorders in laparoscopic sleeve gastrectomy patients: does it affect early weight loss? Surg Obes Relat Dis. 2010;6(2):191–196.CrossRefPubMed Semanscin-Doerr DA, Windover A, Ashton K, Heinberg LJ. Mood disorders in laparoscopic sleeve gastrectomy patients: does it affect early weight loss? Surg Obes Relat Dis. 2010;6(2):191–196.CrossRefPubMed
13.
Zurück zum Zitat Daumit GL, Dickerson FB, Wang N-Y, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013;368(17):1594–1602.CrossRefPubMedPubMedCentral Daumit GL, Dickerson FB, Wang N-Y, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013;368(17):1594–1602.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Brown C, Goetz J, Hamera E. Weight loss intervention for people with serious mental illness: a randomized controlled trial of the RENEW program. Psychiatr Serv. 2011;62(7):800–802.CrossRefPubMedPubMedCentral Brown C, Goetz J, Hamera E. Weight loss intervention for people with serious mental illness: a randomized controlled trial of the RENEW program. Psychiatr Serv. 2011;62(7):800–802.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Moyer VA. US Preventive Services Task Force. Screening for and management of obesity in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(5):373–378.PubMed Moyer VA. US Preventive Services Task Force. Screening for and management of obesity in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(5):373–378.PubMed
16.
Zurück zum Zitat Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005;66(2):205–212.CrossRefPubMed Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2005;66(2):205–212.CrossRefPubMed
17.
Zurück zum Zitat McKibbin CL, Golshan S, Griver K, Kitchen K, Wykes TL. A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis. Schizophr Res. 2010;121(1–3):203–206.CrossRefPubMed McKibbin CL, Golshan S, Griver K, Kitchen K, Wykes TL. A healthy lifestyle intervention for middle-aged and older schizophrenia patients with diabetes mellitus: a 6-month follow-up analysis. Schizophr Res. 2010;121(1–3):203–206.CrossRefPubMed
18.
Zurück zum Zitat Wu M-K, Wang C-K, Bai Y-M, Huang C-Y, Lee S-D. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv. 2007;58(4):544–550.CrossRefPubMed Wu M-K, Wang C-K, Bai Y-M, Huang C-Y, Lee S-D. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv. 2007;58(4):544–550.CrossRefPubMed
19.
Zurück zum Zitat Brown C, Goetz J, Hamera E, Gajewski B. Treatment response to the RENEW weight loss intervention in schizophrenia: impact of intervention setting. Schizophr Res. 2014;159(2–3):421–425.CrossRefPubMedPubMedCentral Brown C, Goetz J, Hamera E, Gajewski B. Treatment response to the RENEW weight loss intervention in schizophrenia: impact of intervention setting. Schizophr Res. 2014;159(2–3):421–425.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Gill KJ, Zechner M, Zambo Anderson E, Swarbrick M, Murphy A. Wellness for life: A pilot of an interprofessional intervention to address metabolic syndrome in adults with serious mental illnesses. Psychiatr Rehabil J. 2016;39(2):147–153.CrossRefPubMed Gill KJ, Zechner M, Zambo Anderson E, Swarbrick M, Murphy A. Wellness for life: A pilot of an interprofessional intervention to address metabolic syndrome in adults with serious mental illnesses. Psychiatr Rehabil J. 2016;39(2):147–153.CrossRefPubMed
21.
Zurück zum Zitat McGinty EE, Baller J, Azrin ST, et al. Interventions to address medical conditions and health-risk behaviors among persons with serious mental illness: a comprehensive review. Schizophr Bull. 2016;42(1):96–124.PubMed McGinty EE, Baller J, Azrin ST, et al. Interventions to address medical conditions and health-risk behaviors among persons with serious mental illness: a comprehensive review. Schizophr Bull. 2016;42(1):96–124.PubMed
22.
Zurück zum Zitat Kumar AA. Palamaner Subash Shantha G, Kahan S, Samson RJ, Boddu ND, Cheskin LJ. Intentional weight loss and dose reductions of anti-diabetic medications—a retrospective cohort study. PLoS One. 2012;7(2):e32395.CrossRefPubMedPubMedCentral Kumar AA. Palamaner Subash Shantha G, Kahan S, Samson RJ, Boddu ND, Cheskin LJ. Intentional weight loss and dose reductions of anti-diabetic medications—a retrospective cohort study. PLoS One. 2012;7(2):e32395.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Shantha GPS, Kumar AA, Kahan S, Cheah SY, Cheskin LJ. Intentional weight loss and dose reductions of antihypertensive medications: a retrospective cohort study. Cardiorenal Med. 2013;3(1):17–25.CrossRefPubMedPubMedCentral Shantha GPS, Kumar AA, Kahan S, Cheah SY, Cheskin LJ. Intentional weight loss and dose reductions of antihypertensive medications: a retrospective cohort study. Cardiorenal Med. 2013;3(1):17–25.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Redmon JB, Bertoni AG, Connelly S, et al. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2010;33(6):1153–1158.CrossRefPubMedPubMedCentral Redmon JB, Bertoni AG, Connelly S, et al. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care. 2010;33(6):1153–1158.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Erickson ZD, Mena SJ, Pierre JM, et al. Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial. J Clin Psychiatry. 2016;77(2):e183–189.CrossRefPubMed Erickson ZD, Mena SJ, Pierre JM, et al. Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial. J Clin Psychiatry. 2016;77(2):e183–189.CrossRefPubMed
26.
Zurück zum Zitat Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–2171.CrossRef Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165–2171.CrossRef
27.
Zurück zum Zitat Wirshing DA, Sergi MJ, Mintz J. A videotape intervention to enhance the informed consent process for medical and psychiatric treatment research. Am J Psychiatry. 2005;162(1):186–188.CrossRefPubMed Wirshing DA, Sergi MJ, Mintz J. A videotape intervention to enhance the informed consent process for medical and psychiatric treatment research. Am J Psychiatry. 2005;162(1):186–188.CrossRefPubMed
28.
Zurück zum Zitat Overall JE, Gorham DR. The brief psychiatric rating scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull. 1988;24(1):97–99. Overall JE, Gorham DR. The brief psychiatric rating scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol Bull. 1988;24(1):97–99.
29.
Zurück zum Zitat Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: US Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs. 1976. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: US Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs. 1976.
30.
Zurück zum Zitat Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.CrossRefPubMed Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296.CrossRefPubMed
31.
Zurück zum Zitat Beck A, Steer R. Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corp.; 1993. Beck A, Steer R. Beck Anxiety Inventory Manual. San Antonio, TX: Psychological Corp.; 1993.
32.
Zurück zum Zitat Weiden PJ, Miller AL. Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J Psychiatr Pract. 2001;7(1):41–47.CrossRefPubMed Weiden PJ, Miller AL. Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J Psychiatr Pract. 2001;7(1):41–47.CrossRefPubMed
33.
Zurück zum Zitat McConnaughy E, Prochaska J, Velicer W. Stages of change in psychotherapy: measurements and sample profiles. Psychotherapy. 1983;20:368–375.CrossRef McConnaughy E, Prochaska J, Velicer W. Stages of change in psychotherapy: measurements and sample profiles. Psychotherapy. 1983;20:368–375.CrossRef
34.
Zurück zum Zitat McConnaughy E, DiClemente C, Prochaska J, Velicer W. Stages of change in psychotherapy: a follow-up report. Psychotherapy. 1989;26:494–503.CrossRef McConnaughy E, DiClemente C, Prochaska J, Velicer W. Stages of change in psychotherapy: a follow-up report. Psychotherapy. 1989;26:494–503.CrossRef
35.
Zurück zum Zitat DiClemente CC, Hughes SO. Stages of change profiles in outpatient alcoholism treatment. J Subst Abuse. 1990;2(2):217–235.CrossRefPubMed DiClemente CC, Hughes SO. Stages of change profiles in outpatient alcoholism treatment. J Subst Abuse. 1990;2(2):217–235.CrossRefPubMed
36.
Zurück zum Zitat Marks KA, Fastenau PS, Lysaker PH, Bond GR. Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res. 2000;45(3):203–211.CrossRefPubMed Marks KA, Fastenau PS, Lysaker PH, Bond GR. Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia. Schizophr Res. 2000;45(3):203–211.CrossRefPubMed
37.
Zurück zum Zitat WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–1409.CrossRef WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403–1409.CrossRef
38.
Zurück zum Zitat First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I). New York, NY: Biometric Research Department; 1997. First M, Spitzer R, Gibbon M, Williams J. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I). New York, NY: Biometric Research Department; 1997.
39.
Zurück zum Zitat Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497.
40.
Zurück zum Zitat Balady GJ, Chaitman B, Driscoll D, et al. American College of Sports Medicine Position Stand and American Heart Association. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Med Sci Sports Exerc. 1998;30(6):1009–1018. Balady GJ, Chaitman B, Driscoll D, et al. American College of Sports Medicine Position Stand and American Heart Association. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Med Sci Sports Exerc. 1998;30(6):1009–1018.
41.
Zurück zum Zitat Kwan CL, Gelberg HA, Rosen JA, et al. Nutritional counseling for adults with severe mental illness: key lessons learned. J Acad Nutr Diet. 2014;114(3):369–374.CrossRefPubMed Kwan CL, Gelberg HA, Rosen JA, et al. Nutritional counseling for adults with severe mental illness: key lessons learned. J Acad Nutr Diet. 2014;114(3):369–374.CrossRefPubMed
42.
Zurück zum Zitat Moshfegh AJ, Rhodes DG, Baer DJ, et al. The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr. 2008;88(2):324–332.PubMed Moshfegh AJ, Rhodes DG, Baer DJ, et al. The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am J Clin Nutr. 2008;88(2):324–332.PubMed
43.
Zurück zum Zitat Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot AJHP. 1997;12(1):38–48.CrossRefPubMed Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot AJHP. 1997;12(1):38–48.CrossRefPubMed
44.
Zurück zum Zitat Wenzel A, Brown GK, Karlin BE. Cognitive Behavioral Therapy for Depression in Veterans and Military Servicemembers: Therapist Manual. Washington, DC: US Department of Veterans Affairs; 2011. Wenzel A, Brown GK, Karlin BE. Cognitive Behavioral Therapy for Depression in Veterans and Military Servicemembers: Therapist Manual. Washington, DC: US Department of Veterans Affairs; 2011.
45.
Zurück zum Zitat Rüsch N, Corrigan PW. Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatr Rehabil J. 2002;26(1):23–32.CrossRefPubMed Rüsch N, Corrigan PW. Motivational interviewing to improve insight and treatment adherence in schizophrenia. Psychiatr Rehabil J. 2002;26(1):23–32.CrossRefPubMed
46.
Zurück zum Zitat Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. New York, NY: Guilford Press; 2012. Miller WR, Rollnick S. Motivational Interviewing: Helping People Change. New York, NY: Guilford Press; 2012.
48.
Zurück zum Zitat Liberman RP, Glynn S, Blair KE, et al. In vivo amplified skills training: promoting generalization of independent living skills for clients with schizophrenia. Psychiatry. 2002;65(2):137–55.CrossRefPubMed Liberman RP, Glynn S, Blair KE, et al. In vivo amplified skills training: promoting generalization of independent living skills for clients with schizophrenia. Psychiatry. 2002;65(2):137–55.CrossRefPubMed
49.
Zurück zum Zitat Gelberg HA, Kwan CL, Mena SJ, et al. Meal replacements as a weight loss tool in a population with severe mental illness. Eat Behav. 2015;19:61–64.CrossRefPubMed Gelberg HA, Kwan CL, Mena SJ, et al. Meal replacements as a weight loss tool in a population with severe mental illness. Eat Behav. 2015;19:61–64.CrossRefPubMed
50.
Zurück zum Zitat Goodrich DE, Klingaman EA, Verchinina L, et al. Sex differences in weight loss among veterans with serious mental illness: observational study of a national weight management program. Womens Health Issues. 2016. Goodrich DE, Klingaman EA, Verchinina L, et al. Sex differences in weight loss among veterans with serious mental illness: observational study of a national weight management program. Womens Health Issues. 2016.
51.
Zurück zum Zitat Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–138.CrossRefPubMed Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–138.CrossRefPubMed
52.
Zurück zum Zitat Vazin R, McGinty EE, Dickerson F, et al. Perceptions of strategies for successful weight loss in persons with serious mental illness participating in a behavioral weight loss intervention: a qualitative study. Psychiatr Rehabil J. 2016;39(2):137–46. Vazin R, McGinty EE, Dickerson F, et al. Perceptions of strategies for successful weight loss in persons with serious mental illness participating in a behavioral weight loss intervention: a qualitative study. Psychiatr Rehabil J. 2016;39(2):137–46.
53.
54.
Zurück zum Zitat Honas JJ, Early JL, Frederickson DD, O’Brien MS. Predictors of attrition in a large clinic-based weight-loss program. Obes Res. 2003;11(7):888–894.CrossRefPubMed Honas JJ, Early JL, Frederickson DD, O’Brien MS. Predictors of attrition in a large clinic-based weight-loss program. Obes Res. 2003;11(7):888–894.CrossRefPubMed
55.
Zurück zum Zitat Spring B, Sohn M-W, Locatelli SM, Hadi S, Kahwati L, Weaver FM. Individual, facility, and program factors affecting retention in a national weight management program. BMC Public Health. 2014;14:363.CrossRefPubMedPubMedCentral Spring B, Sohn M-W, Locatelli SM, Hadi S, Kahwati L, Weaver FM. Individual, facility, and program factors affecting retention in a national weight management program. BMC Public Health. 2014;14:363.CrossRefPubMedPubMedCentral
Metadaten
Titel
A Randomized, Controlled Multisite Study of Behavioral Interventions for Veterans with Mental Illness and Antipsychotic Medication-Associated Obesity
verfasst von
Zachary D. Erickson, BA, CCRP
Crystal L. Kwan, MPH, RD, CDE
Hollie A. Gelberg, PhD, RD
Irina Y. Arnold, MS, MD
Valery Chamberlin, MD
Jennifer A. Rosen, PharmD, BCPP
Chandresh Shah, MD
Charles T. Nguyen, MD
Gerhard Hellemann, PhD
Dixie R. Aragaki, MD
Charles F. Kunkel, MD
Melissa M. Lewis, PhD
Neena Sachinvala, MD
Patrick A. Sonza, RN
Joseph M. Pierre, MD
Donna Ames, MD
Publikationsdatum
07.03.2017
Verlag
Springer US
Erschienen in
Journal of General Internal Medicine / Ausgabe Sonderheft 1/2017
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-016-3960-3

Weitere Artikel der Sonderheft 1/2017

Journal of General Internal Medicine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.